A detailed history of Dodge & Cox transactions in Boston Scientific Corp stock. As of the latest transaction made, Dodge & Cox holds 95,295 shares of BSX stock, worth $9.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95,295
Previous 97,095 1.85%
Holding current value
$9.75 Million
Previous $7.48 Million 6.79%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $131,328 - $151,200
-1,800 Reduced 1.85%
95,295 $7.99 Million
Q4 2023

Feb 15, 2024

SELL
$48.64 - $57.81 $486 - $578
-10 Reduced 0.01%
97,095 $5.61 Million
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $89,087 - $97,057
-1,775 Reduced 1.8%
97,105 $5.13 Million
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $333,621 - $366,634
-6,710 Reduced 6.35%
98,880 $5.35 Million
Q1 2023

May 12, 2023

SELL
$45.09 - $50.03 $329,157 - $365,219
-7,300 Reduced 6.47%
105,590 $5.28 Million
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $106,812 - $127,494
-2,700 Reduced 2.34%
112,890 $5.22 Million
Q3 2022

Nov 10, 2022

SELL
$36.71 - $109.66 $183,550 - $548,300
-5,000 Reduced 4.15%
115,590 $4.48 Million
Q1 2022

May 13, 2022

SELL
$40.9 - $45.1 $204,500 - $225,500
-5,000 Reduced 3.98%
120,590 $5.34 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $171,315 - $201,915
-4,500 Reduced 3.46%
125,590 $5.34 Million
Q2 2021

Aug 13, 2021

SELL
$38.58 - $44.24 $46,296 - $53,088
-1,200 Reduced 0.91%
130,090 $5.56 Million
Q1 2021

May 14, 2021

SELL
$35.27 - $39.67 $59,959 - $67,439
-1,700 Reduced 1.28%
131,290 $5.07 Million
Q4 2020

Feb 11, 2021

SELL
$33.15 - $41.97 $165,750 - $209,850
-5,000 Reduced 3.62%
132,990 $4.78 Million
Q3 2020

Nov 13, 2020

SELL
$34.44 - $42.23 $175,644 - $215,372
-5,100 Reduced 3.56%
137,990 $5.27 Million
Q2 2020

Aug 13, 2020

SELL
$30.19 - $39.11 $656,632 - $850,642
-21,750 Reduced 13.19%
143,090 $5.02 Million
Q1 2020

May 14, 2020

SELL
$25.83 - $45.71 $247,967 - $438,816
-9,600 Reduced 5.5%
164,840 $5.38 Million
Q4 2019

Feb 13, 2020

SELL
$37.87 - $45.37 $7,573 - $9,074
-200 Reduced 0.11%
174,440 $7.89 Million
Q3 2019

Nov 13, 2019

SELL
$40.31 - $43.45 $80,620 - $86,900
-2,000 Reduced 1.13%
174,640 $7.11 Million
Q2 2019

Aug 13, 2019

SELL
$34.91 - $42.98 $3,665 - $4,512
-105 Reduced 0.06%
176,640 $7.59 Million
Q1 2019

May 14, 2019

SELL
$32.91 - $40.75 $660,339 - $817,648
-20,065 Reduced 10.2%
176,745 $6.78 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $236,229 - $290,652
-7,445 Reduced 3.64%
196,810 $6.96 Million
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $252,791 - $297,451
-7,700 Reduced 3.63%
204,255 $7.86 Million
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $708,576 - $906,048
-26,400 Reduced 11.08%
211,955 $6.93 Million
Q1 2018

May 14, 2018

SELL
$25.2 - $28.54 $378,000 - $428,100
-15,000 Reduced 5.92%
238,355 $6.51 Million
Q4 2017

Feb 14, 2018

SELL
$24.79 - $29.8 $1.21 Million - $1.46 Million
-49,000 Reduced 16.21%
253,355 $6.28 Million
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $7.94 Million - $8.82 Million
302,355
302,355 $8.82 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $146B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Dodge & Cox Portfolio

Follow Dodge & Cox and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dodge & Cox, based on Form 13F filings with the SEC.

News

Stay updated on Dodge & Cox with notifications on news.